NeuroCME
LECTURECMECNE

Best of MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care

Author(s)/Faculty: Bruce A. Cohen, MD; Patrick K. Coyle, MD; Clyde E. Markowitz, MD; Claire S. Riley, MD
Release Date: 1/24/2020Expiration Date: 1/23/2021
Credit Type: CME / CNENumber of Credits: 1.75
Content Type: LectureProvider:
Multiple sclerosis (MS) is a chronic, often disabling disease that attacks the central nervous system. The management of patients with MS is highly complex, and the development of disease-modifying therapies (DMTs) has dramatically altered the treatment paradigm. Clinicians need to be updated on new evidence-based recommendations on the use of DMTs from the American Academy of Neurology Guidelines released in 2018. Another important aspect of caring for patients with MS is communication. Patients must be not only educated about their disease and treatment options, but also engaged in conversations about their risk tolerance, quality of life—including symptoms that they are experiencing—and any concerns they may have regarding their care. Shared decision-making is a model of 2-way communication between a patient and a provider with established ability to improve a patient’s satisfaction of care. In this CME/CNE activity, MS Forum® VI, current treatment guidelines, gender-based issues, environmental factors, and comorbidities in MS are discussed alongside the safety, efficacy, and use of current DMTs.